COVID-19 Vaccines with WHO Emergency Use Listing



Vaccine WHO EUL Holder NRA of record Date of EUL Recommendation 
COMIRNATY®
COVD-19 mRNA Vaccine (nucleoside modified)
BioNTech  Manufacturing GmbH

European Medicines Agency (EMA)


Food and Drug Administration (FDA)

31 December 2020

 

16 July 2021

COMIRNATY®Original/Omicron BA.1
COVD-19 mRNA Vaccine (nucleoside modified)
BioNTech  Manufacturing GmbH European Medicines Agency (EMA) 19 October2022
COMIRNATY®Original/Omicron BA.4-5
COVD-19 mRNA Vaccine (nucleoside modified)
BioNTech  Manufacturing GmbH European Medicines Agency (EMA) 11 November 2022

VAXZEVRIA
COVID-19 Vaccine (ChAdOx1-S [recombinant])

 

AstraZeneca AB / SK Bioscience Co. Ltd

 


AstraZeneca AB

 

 

 

 

 

 

 

 

 

 

 

Ministry of Food and Drug Safety (MFDS)

 

European Medicines Agency

 

Ministry of Health, Labour and Welfare

 

Therapeutic Goods Administration

 

Health Canada
 

COFEPRIS (DP)

ANMAT (DS)

 


15 February 2021
 

 

15 April 2021




09 July 2021

 


09 July 2021

 

21 August 2021

 

23 December 2021

 

 

COVISHIELD™
COVID-19 Vaccine (ChAdOx1-S [recombinant])

Serum Institute of India Pvt. Ltd

Central Drugs Standard Control Organization 15 February 2021
COVID-19 Vaccine  (Ad26.COV2-S [recombinant]) Janssen–Cilag International NV European Medicines Agency 12 March 2021
SPIKEVAX
COVID-19 mRNA Vaccine (nucleoside modified)

Moderna Biotech

 

 


ModernaTX, Inc
 

European Medicines Agency

Ministry of Food and Drug Safety (MFDS)


Food and Drug Administration

30 April 2021


23 December 2021



06 August 2021

 

Inactivated COVID-19 Vaccine (Vero Cell) Beijing Institute of Biological Products Co., Ltd. (BIBP) National Medicinal Products Administration (NMPA) 07 May 2021
CoronaVac
COVID-19 Vaccine (Vero Cell), Inactivated
Sinovac Life Sciences Co., Ltd National Medicinal Products Administration (NMPA) 01 June 2021
COVAXIN®
Covid-19 vaccine (Whole Virion Inactivated Corona Virus vaccine)
 
Bharat Biotech International Ltd Central Drugs Standard Control Organization

03 November 2021

Suspension of supply


COVOVAX™
COVID-19 vaccine (SARS-CoV-2 rS Protein Nanoparticle [Recombinant])
 
Serum Institute of India Pvt. Ltd

Central Drugs Standard Control Organization

17 December 2021

NUVAXOVID™
COVID-19 vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted])

Novavax CZ a.s. European Medicines Agency 20 December 2021

CONVIDECIA 
COVID-19 Vaccine (Ad5-nCoV-S [Recombinant]) 

CanSino Biologics Inc. National Medical Products Administration (NMPA)   19 May 2022